INOVIO PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inovio Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Inovio Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 26M shares, a 90.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 26M -242M -90.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 23.4M -239M -91.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 22.8M +1.7M +8.07% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 270M +20.2M +8.12% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 268M +20.6M +8.31% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 263M +36.2M +16% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 21.1M -196M -90.3% Dec 31, 2022 10-K 2024-03-06
Q3 2022 249M +39.1M +18.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 248M +37.4M +17.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 227M +17.2M +8.21% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 217M +30.5M +16.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 210M +42.8M +25.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 210M +51.4M +32.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 209M +63.4M +43.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 187M +85.5M +84.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 168M +68.5M +69.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 159M +60.2M +61% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 146M +48M +49% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 101M +4.14M +4.25% Dec 31, 2019 10-K 2021-03-01
Q3 2019 99M +4.57M +4.84% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 98.6M +7.11M +7.77% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 97.9M +7.23M +7.97% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 97.2M +6.87M +7.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 94.5M +4.18M +4.63% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 91.5M +13.8M +17.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 90.7M +16.1M +21.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 90.4M +16.3M +22% Dec 31, 2017 10-K 2019-03-12
Q3 2017 90.3M +16.3M +22.1% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 77.6M +4.15M +5.65% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 74.6M +2.36M +3.26% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 74.1M +1.84M +2.55% Dec 31, 2016 10-K 2018-03-14
Q3 2016 74M +1.79M +2.47% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 73.5M +1.67M +2.33% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 72.3M +11.5M +19% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 72.2M +11.5M +18.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 72.2M +11.7M +19.4% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 71.8M +11.5M +19.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 60.7M -179M -74.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 60.7M +8.16M +15.5% Dec 31, 2014 10-K 2016-03-14
Q3 2014 60.5M -147M -70.9% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 60.3M -120M -66.5% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 240M +60.2M +33.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 52.6M -91.7M -63.6% Dec 31, 2013 10-K 2015-03-16
Q3 2013 208M Sep 30, 2013 10-Q 2013-11-12
Q2 2013 180M Jun 30, 2013 10-Q 2013-08-09
Q1 2013 180M Mar 31, 2013 10-Q 2013-05-10
Q4 2012 144M +9.34M +6.92% Dec 31, 2012 10-K 2014-03-17
Q4 2011 135M +29.9M +28.5% Dec 31, 2011 10-K 2013-03-18
Q4 2010 105M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.